STOCK TITAN

Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Natera, a global leader in cell-free DNA and genetic testing, will present at the 2024 Leerink Partners Healthcare Crossroads Conference. The presentation is scheduled for Thursday, May 30, 2024, at 8:40 a.m. PT (11:40 a.m. ET). The event will be live-streamed on the investor relations section of Natera's website, with a replay available shortly after.

Positive
  • Natera is recognized as a global leader in cell-free DNA and genetic testing.
  • Participation in a high-profile event like the 2024 Leerink Partners Healthcare Crossroads Conference may increase Natera's visibility among investors and industry stakeholders.
  • The live webcast and replay availability enhance accessibility for a broader audience.
Negative
  • No new financial or clinical data updates were provided in the announcement.
  • There is no immediate impact on revenue or profitability mentioned in the PR.

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of Natera’s management will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Thursday, May 30, 2024 at 8:40 a.m. PT (11:40 a.m. ET).

A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

Source: Natera, Inc.

FAQ

When will Natera present at the 2024 Leerink Partners Healthcare Crossroads Conference?

Natera will present on Thursday, May 30, 2024, at 8:40 a.m. PT (11:40 a.m. ET).

How can I access Natera's presentation at the Leerink Partners Healthcare Crossroads Conference?

A live webcast of the presentation will be available on the investor relations section of Natera's website, with a replay accessible shortly afterward.

What is Natera's stock symbol?

Natera's stock symbol is NASDAQ: NTRA.

What is Natera known for?

Natera is known for being a global leader in cell-free DNA and genetic testing.

Natera, Inc.

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Stock Data

18.19B
123.68M
3.68%
98.19%
3.06%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
AUSTIN